HCW Biologics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $135 | $6,543 | $27 | $15 |
Gross Profit | -93 | 6,531 | 5 | 3 |
EBITDA | -4,972 | 3,835 | 1,102 | -4,237 |
EBIT | -5,099 | 3,693 | 945 | -4,411 |
Net Income | -5,219 | 4,132 | 719 | -4,554 |
Net Change In Cash | 135 | 6,543 | 27 | 15 |
Free Cash Flow | -3,966 | -1,575 | -3,355 | -3,239 |
Cash | 741 | 1,228 | 1,952 | 1,096 |
Basic Shares | 349 | 349 | 349 | 376 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $54 | $2,566 | $2,841 | $6,722 |
Gross Profit | 10 | 959 | 560 | 2,586 |
EBITDA | -5,667 | -27,680 | -23,576 | -14,056 |
EBIT | -6,709 | -28,865 | -24,711 | -14,774 |
Net Income | -7,959 | -30,023 | -24,994 | -14,900 |
Net Change In Cash | 54 | 2,566 | 2,841 | 6,722 |
Cost of Revenue | 10,595 | |||
Free Cash Flow | -13,391 | -14,489 | -28,716 | -20,661 |
Cash | 1,952 | 4,674 | 3,595 | 22,326 |
Basic Shares | 349 | 6,465 | 5,988 | 5,970 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$10.10 |
2026-03-31 | $2.22 |
2025-12-31 | -$6.12 |
2025-09-30 | -$12.12 |